CLB

Core Labs
NYSE

Real-time Quotes | Nasdaq Last Sale

15.35
+0.38
+2.54%
After Hours: 15.35 0 0.00% 16:12 10/23 EDT
OPEN
15.00
PREV CLOSE
14.97
HIGH
15.72
LOW
14.88
VOLUME
590.03K
TURNOVER
--
52 WEEK HIGH
49.22
52 WEEK LOW
6.68
MARKET CAP
682.83M
P/E (TTM)
-8.5487
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Core Labs' (CLB) Q3 Earnings Beat Estimates, Revenues Miss Mark
Zacks · 2d ago
Core Laboratories EPS beats by $0.01, misses on revenue
Core Laboratories (CLB): Q3 Non-GAAP EPS of $0.16 beats by $0.01; GAAP EPS of $0.07 misses by $0.07.Revenue of $105.38M (-39.2% Y/Y) misses by $3.95M.Shares +1% AH.Press Release
Seekingalpha · 3d ago
Core Laboratories Q3 Adj. EPS $0.16 Beats $0.15 Estimate, Sales $105.38M Miss $112.73M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 by 6.67 percent. This is a 68 percent decrease over earnings of $0.50 per share from the same
Benzinga · 3d ago
Core Labs Appears Fully Valued Into Earnings
Core Labs reports earnings on October 21st. Revenue is expected to fall by double digits amid demand destruction for oil.The company is rightsizing its cost structure, but cost take-outs may not fully offset declining scale in Q3.At just under 14x EBITDA, Core Labs appears fully valued. I rate the stock a Hold.
Seekingalpha · 4d ago
Notable earnings after Wednesday's close
[[ALGN]], [[BCOV]], [[BDN]], [[CCI]], [[CLB]], [[CMG]], [[CNS]], [[CSX]], [[CVBF]], [[DFS]], [[EFX]], [[EW]], [[FR]], [[FTI]], [[GGG]], [[GL]], [[ICLR]], [[KALU]], [[KMI]], [[LRCX]], [[LSTR]], [[LVS]], [[MTH]], [[NTGR]], [[NWE]], [[SEIC]], [[SLG]], [[SLM]], [[STL]], [[SUI]],
Seekingalpha · 4d ago
Core Laboratories Q3 2020 Earnings Preview
Core Laboratories (NYSE:CLB) is scheduled to announce Q3 earnings results on Wednesday, October 21st, after market close.The consensus EPS Estimate is $0.15 and the consensus Revenue Estimate is $109.33M (-36.9% Y/Y).Over
Seekingalpha · 4d ago
A Preview Of Core Laboratories's Earnings
On Wednesday, October 21, Core Laboratories (NYSE: CLB) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.What Are Earnings, Net Income, And Earnings Per Share (EPS)? Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.Earnings And Revenue Wall Street analysts see Core Laboratories reporting earnings of $0.16 per share on revenue of $114.04 million. In the same quarter last year, Core Laboratories reported EPS of $0.5 on revenue of $173.20 million.Why Analyst Estimates And Earnings Surprises Are Important Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a given company yields the "consensus estimates." If the company posts earnings or revenue above or below the consensus estimate, the stock may move by a considerable margin.View more earnings on CLBIf the company were to match the consensus estimate when it reports Wednesday, earnings would be down 68.0%. Revenue would be down 34.16% on a year-over-year basis. Core Laboratories's reported EPS has stacked up against analyst estimates in the past like this:Quarter Q2 2020 Q1 2020 Q4 2020 Q3 2019 EPS Estimate 0.10 0.35 0.37 0.49 EPS Actual 0.14 0.31 0.38 0.50 Revenue Estimate 115.35 M 153.86 M 156.04 M 171.79 M Revenue Actual 115.74 M 152.40 M 156.78 M 173.20 M Stock Performance Shares of Core Laboratories were trading at $14.84 as of October 19. Over the last 52-week period, shares are down 65.48%. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.Do not be surprised to see the stock move on comments made during its conference call. Core Laboratories is scheduled to hold the call at 08:30:00 ET and can be accessed here: https://www.webcaster4.com/Webcast/Page/1000/37733See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Benzinga's Top Upgrades, Downgrades For September 29, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 5d ago
What's in Store for Core Laboratories (CLB) in Q3 Earnings?
Core Laboratories' (CLB) Production Enhancement unit is expected to have incurred operating loss in Q3, same as the previous quarter.
Zacks · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CLB. Analyze the recent business situations of Core Labs through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CLB stock price target is 20.00 with a high estimate of 26.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 405
Institutional Holdings: 57.31M
% Owned: 128.84%
Shares Outstanding: 44.48M
TypeInstitutionsShares
Increased
56
6.01M
New
71
3.59M
Decreased
66
13.11M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Oil Related Services and Equipment
+0.08%
Oil & Gas Related Equipment and Services
-0.57%
Key Executives
Chairman - Supervisory/Chief Executive Officer/Director
Lawrence Bruno
Chief Financial Officer/Senior Vice President
Christopher Hill
General Counsel/Secretary
Mark Elvig
Lead Director/Independent Director
Martha Carnes
Independent Director/Supervisory Board
Gregory Barnett
Independent Director/Supervisory Board
Harvey Klingensmith
Independent Director/Supervisory Board
Michael Straughen
Independent Director/Supervisory Board
Monique Van Dijken Eeuwijk
Independent Director/Supervisory Board
Margaret van Kempen
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
10/15/2020
Dividend USD 0.01
10/23/2020
07/17/2020
Dividend USD 0.01
07/24/2020
04/28/2020
Dividend USD 0.01
05/07/2020
01/14/2020
Dividend USD 0.25
01/23/2020
10/08/2019
Dividend USD 0.55
10/17/2019
07/12/2019
Dividend USD 0.55
07/19/2019
04/16/2019
Dividend USD 0.55
04/25/2019
01/15/2019
Dividend USD 0.55
01/24/2019
10/09/2018
Dividend USD 0.55
10/18/2018
07/13/2018
Dividend USD 0.55
07/20/2018
04/17/2018
Dividend USD 0.55
04/26/2018
01/16/2018
Dividend USD 0.55
01/25/2018
10/10/2017
Dividend USD 0.55
10/19/2017
07/07/2017
Dividend USD 0.55
07/13/2017
04/19/2017
Dividend USD 0.55
04/26/2017
01/11/2017
Dividend USD 0.55
01/18/2017
10/12/2016
Dividend USD 0.55
10/19/2016
07/07/2016
Dividend USD 0.55
07/14/2016
04/15/2016
Dividend USD 0.55
05/02/2016
01/11/2016
Dividend USD 0.55
01/20/2016
10/14/2015
Dividend USD 0.55
10/21/2015
07/08/2015
Dividend USD 0.55
07/15/2015
04/23/2015
Dividend USD 0.55
04/22/2015
01/12/2015
Dividend USD 0.55
01/21/2015
10/08/2014
Dividend USD 0.5
10/15/2014
08/19/2014
Dividend USD 0.5
07/16/2014
04/15/2014
Dividend USD 0.5
04/23/2014
01/14/2014
Dividend USD 0.5
01/22/2014
10/15/2013
Dividend USD 0.32
10/16/2013
07/18/2013
Dividend USD 0.32
07/17/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CLB
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Core Laboratories N.V. stock information, including NYSE:CLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CLB stock methods without spending real money on the virtual paper trading platform.